Replies to post #5467 on Jiangbo Pharmaceuticals, Inc.(fka JGBO)

[996]

Best promotion would be the news on a date of uplisting to Nasdaq. Then investors will notice. As long as we will stay on the OTCBB I don't see a big rise in shareprice. Present times are too uncertain for that.
After we are uplisted we'll need news on the new drugs to prove that we still will be able to grow 30% every year and keep the profitability.